Research status and prospect of tissue engineering technology in treatment of atrophic rhinitis.
10.7507/1002-1892.202301064
- Author:
Shuting LEI
1
;
Juanjuan HU
1
;
Yingqi TANG
2
;
Weigang GAN
3
;
Yuting SONG
1
;
Yanlin JIANG
1
;
Honghui ZHANG
3
;
Yaya GAO
1
;
Hui YANG
3
;
Huiqi XIE
1
Author Information
1. Laboratory of Stem Cell and Tissue Engineering, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P. R. China.
2. West China School of Public Health, Sichuan University, Chengdu Sichuan, 610041, P. R. China.
3. Department of Otolaryngology Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu Sichuan, 610041, P. R. China.
- Publication Type:Journal Article
- Keywords:
Atrophic rhinitis;
repair and reconstruction;
tissue engineering technology
- MeSH:
Humans;
Tissue Engineering/methods*;
Tissue Scaffolds;
Rhinitis, Atrophic;
Printing, Three-Dimensional;
Cytokines
- From:
Chinese Journal of Reparative and Reconstructive Surgery
2023;37(6):727-731
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To review the research progress of the feasibility of a new treatment method for atrophic rhinitis (ATR) based on tissue engineering technology (seed cells, scaffold materials, and growth factors), and provide new ideas for the treatment of ATR.
METHODS:The literature related to ATR was extensively reviewed. Focusing on the three aspects of seed cells, scaffold materials, and growth factors, the recent research progress of ATR treatment was reviewed, and the future directions of tissue engineering technology to treat ATR were proposed.
RESULTS:The pathogenesis and etiology of ATR are still unclear, and the effectiveness of the current treatments are still unsatisfactory. The construction of a cell-scaffold complex with sustained and controlled release of exogenous cytokines is expected to reverse the pathological changes of ATR, promoting the regeneration of normal nasal mucosa and reconstructing the atrophic turbinate. In recent years, the research progress of exosomes, three-dimensional printing, and organoids will promote the development of tissue engineering technology for ATR.
CONCLUSION:Tissue engineering technology can provide a new treatment method for ATR.
